Deep Track Capital - Massinvestor Venture Capital and Private Equity Database

HF Deep Track Capital

https://www.deeptrackcapital.com/

Office Locations:

200 Greenwich Ave., 3rd Floor
Greenwich, CT 06830
Phone: 203-409-0810

Stages:

Early
Expansion
Growth

Industries:

Life Sciences & Healthcare

Description:

Deep Track Capital is a Greenwich, Connecticut-based investment firm focused exclusively on the life sciences industry. The firm develops long term partnerships with management teams of leading innovative public and pre-IPO biotechnology companies. The firm aims to lead transactions while building large syndicates, and also to invest in rounds led by other qualified investors.

Funds:

Fund Name	Amount	Date
Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

Investment Firm Key

   VC = Venture Capital
   PE = Private Equity
   A = Angel
   I = Incubator
   MB = Merchant Bank
   VD = Venture Debt
   FI = Family Investment Office
   FOF = Fund of Funds
   ED = Economic Development Office
   TT = Technology Transfer Office
   CVC = Corporate Venture Capital
   SEC = Secondary Purchaser
   HF = Hedge Fund/Mutual Fund

COMPANY STAGE	REVENUE
Venture Capital
Seed Stage (includes "pre-seed," or concept stage)	No Revenue
Early Stage	Minimal Revenue
Growth Stage (also called Mid-stage)	$2M-$7M
Expansion Stage (also called Late-stage)	$7M and greater
Private Equity
Lower Middle Market	$10M-$249M
Middle Market	$250M-$499M
Upper Middle Market	$500M-$1B
Large Cap	>$1B

Click Here for a
FREE DEMO
of the #1 VC & PE
Database

▶ 5,000 Firms

▶ 18,000 Partner Emails

▶ 30,000 Portfolio
companies

Investment Team:

Name		Title	Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
David Kroin		Founder and Chief Investment Officer
Gerard Smith	MD/MBA	Principal
Janet Okogbaa	MD	Associate
Nir Messafi	CPA	Chief.Operating.and.Financial.Officer, Chief.Compliance.Officer
Rael Mazansky	MD/MBA	Managing Director

Recent Funding Events (trailing 12 months):

Date	Name	State	Amount	Stage
01/12/2026	Diagonal Therapeutics	MA	$125,000,000	Series B
10/27/2025	Hemab Therapeutics	MA	$157,000,000	Series C
09/22/2025	Avenzo Therapeutics	CA	$60,000,000	Series B
04/10/2025	Imbria Pharmaceuticals	MA	$57,500,000	Series B
03/31/2025	Arbor Biotechnologies	MA	$73,900,000	Series C
03/17/2025	Latigo Biotherapeutics	CA	$150,000,000	Series B